Physician

Irfan Fazil, M.D.

According to 2025 Medicare claims, Irfan Fazil, M.D. (NPI: 1528018819) practices internal medicine in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is YUMA KIDNEY & DIALYSIS SPECIALISTS PC (NPI: 1295229672; TIN: 830929784) and primary practice location at 85367-0001.

Fazil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,209 traditional Medicare patients, billed 258,734 HCPCS/CPT codes, and received $3,397,668 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,266 prescription claims across 577 beneficiaries totaling $610,548 in drug costs, led by Ozempic (Semaglutide). DME data shows 100 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,241,570 and ending at $3,397,668. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $869,802 to $610,548. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,286 to $22,252.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,619	63,804	$1,241,570
2016	1,123	46,730	$1,255,297
2017	1,162	55,821	$1,464,983
2018	1,266	129,033	$2,988,783
2019	838	73,426	$2,321,953
2020	512	20,160	$422,959
2021	305	7,948	$151,856
2022	564	20,689	$432,067
2023	613	25,952	$643,057
2024	1,209	258,734	$3,397,668

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	736	6,762	$869,802
2016	585	5,307	$404,770
2017	626	6,421	$380,277
2018	639	6,566	$345,637
2019	596	6,211	$312,282
2020	543	5,861	$335,728
2021	489	4,975	$310,490
2022	525	5,391	$391,117
2023	609	6,309	$628,782
2024	577	6,266	$610,548

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	228	$11,364
2016	31	100	$3,447
2017	44	110	$2,293
2018	43	195	$4,329
2019	65	205	$3,818
2020	34	159	$5,728
2021	12	25	$773
2022	12	80	$5,348
2023	12	86	$5,313
2024	12	100	$20,723

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	790	2,290	$85
81007	Urinalysis for bacteria	386	15,177	$29
82533	Cortisol (hormone) measurement, total	386	15,185	$16
36415	Insertion of needle into vein for collection of blood sample	386	15,155	$9
82550	Creatine kinase (cardiac enzyme) level, total	386	15,185	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	143	7,328	$207,668
Eliquis	Apixaban	47	2,840	$53,512
Jardiance	Empagliflozin	23	1,998	$37,883
Trulicity	Dulaglutide	20	729	$24,791
Xarelto	Rivaroxaban	12	930	$17,274

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	11	$11,230
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$6,121
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	26	$2,547
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	22	$524
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	18	$286

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Irfan Fazil, M.D.?

Tedicare shows public-source Medicare data for Irfan Fazil, M.D. (NPI 1528018819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Irfan Fazil, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Irfan Fazil, M.D.?

Irfan Fazil, M.D. is linked to YUMA KIDNEY & DIALYSIS SPECIALISTS PC (billing NPI 1295229672) in the available physician profile data.

Does Irfan Fazil, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.